Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
4
Neutral
5
Bullish
5
Bearish
36
Neutral
5
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Indegene Limited is a digital-first life sciences commercialization company, specializing in biopharmaceutical, biotech, and medical device sectors. It combines healthcare domain knowledge with technology to enhance product development and marketing.
The company achieved a significant financial milestone in Q3 FY26 by surpassing $100 million in quarterly revenue for the first time, reflecting over 30% YoY growth.
The successful execution of large AI-driven deals with global pharma leaders indicates Indegene's strategic focus on using Gen AI platforms to transform operations across commercial and medical sectors.
Recent acquisitions of BioPharm and Warn & Co. have diversified and strengthened Indegene’s capabilities in omnichannel and consulting services, enhancing its market position.
Despite challenges, Indegene maintains a robust financial position, with healthy cash reserves and strong cash generation, enabling sustained investment in growth and innovation.
Healthcare
IT Enabled Services / Business Process Outsourcing
11,351 Cr
Low Risk
26.0
23.6
2.0
4.0
632.10
455.80
Sales CAGR
Profit CAGR
ROE
ROCE
Indegene Ltd (INDGN) is currently trading at 472.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Indegene Limited is a digital-first life sciences commercialization company, specializing in biopharmaceutical, biotech, and medical device sectors. It combines healthcare domain knowledge with technology to enhance product development and marketing. The company achieved a significant financial milestone in Q3 FY26 by surpassing $100 million in quarterly revenue for the first time, reflecting over 30% YoY growth. The successful execution of large AI-driven deals with global pharma leaders indicates Indegene's strategic focus on using Gen AI platforms to transform operations across commercial and medical sectors. Recent acquisitions of BioPharm and Warn & Co. have diversified and strengthened Indegene’s capabilities in omnichannel and consulting services, enhancing its market position. Despite challenges, Indegene maintains a robust financial position, with healthy cash reserves and strong cash generation, enabling sustained investment in growth and innovation.
Over the past 52 weeks, Indegene Ltd has traded between a low of ₹455.80 and a high of ₹632.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Indegene Ltd has a market capitalization of approximately 11,350.66. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Indegene Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 26.01 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 11,350.66 Cr, Indegene Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Indegene Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Indegene Ltd is 26.01. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stock
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
630.35 | 15,626 Cr | 33.84 | 12.84 | 2.29 | 38.09 | 47.09 | 26.61 | |
3222.15 | 15,354 Cr | 22.91 | 5.85 | 0.03 | 23.40 | 27.69 | 18.96 | |
216.00 | 15,314 Cr | 24.19 | 3.50 | 1.82 | 15.34 | 14.62 | 7.57 | |
788.00 | 13,533 Cr | 11.79 | 2.73 | 0.00 | 0.00 | 0.00 | 0.00 | |
472.70 | 11,351 Cr | 26.01 | 3.96 | 0.42 | 15.56 | 19.82 | 12.28 | |
257.05 | 10,584 Cr | 16.45 | 4.97 | 0.39 | 28.27 | 29.30 | 20.43 | |
380.05 | 8,185 Cr | -109.21 | 4.66 | 0.00 | 0.44 | 2.77 | 0.00 |
